Etiologies and Outcomes of Normocytic Anemia in Children
Emily Equitz,Jacquelyn M Powers,Susan Kirk,Jacquelyn M. Powers
DOI: https://doi.org/10.1016/j.jpeds.2024.114041
IF: 6.314
2024-03-30
The Journal of Pediatrics
Abstract:Objective To characterize the evaluation and outcomes of children referred to pediatric hematology for normocytic anemia. Study design Retrospective cohort study of children aged 0 to 21 years referred to a tertiary pediatric hematology clinic for normocytic anemia from 2019 through 2021. Normocytic anemia was defined as a low hemoglobin and normal mean corpuscular volume, per the referring laboratory reference range. Results Two-hundred seventy-one patients (48% female, median age 5.4 years) were included. The most common hematologic diagnoses included iron deficiency (n=90, 33%), statistical anemia (n=64, 24%), transient marrow suppression (n=36, 13%), and transient erythroblastopenia of childhood (TEC, n=19, 7%). There were 17 (6%) patients in whom anemia was thought to be secondary to a non-hematologic disorder and therefore were referred to another pediatric specialty. Sixteen patients (6%) had anemia which spontaneously resolved without an underlying etiology being identified. Aside from iron deficient patients, 35 (13%) had diagnoses requiring ongoing hematology care including TEC, hemolytic anemia, Diamond Blackfan Anemia, and abnormal beta globin traits. Two-hundred-fifty-one patients (93%) were discharged from hematology care after a median of 25 days (range 0-2124 days). Conclusion Pediatric patients with normocytic anemia have diverse underlying etiologies with iron deficiency being most common. These data support initial management within the primary care setting including assessment of a serum ferritin, iron panel, and reticulocyte count, with only a subset of patients requiring ongoing subspecialty care.
pediatrics
What problem does this paper attempt to address?